Testosterone / Anastrozole

Manufacturer: Qualgen LLC
Effective date: 2020-07-19
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 9
Source: legacy-cache
Hydrated at: 2026-08-01 23:20:45

Label at a glance#

ProductTestosterone / Anastrozole

Active ingredientANASTROZOLE, TESTOSTERONE

Label structure2 sections

Label contents#

Full prescribing information#

DESCRIPTION SECTION

estradiol 12mg pellet

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

12-Pellet

T-A 222-12

30-Pellet

T-A 222-30

res

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 4 matching rows.

Testosterone / Anastrozole
STEARIC ACID
ANASTROZOLE
TESTOSTERONE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
69761-222	69761-222-12, 69761-222-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
STEARIC ACID	4ELV7Z65AP	IACT
ANASTROZOLE	2Z07MYW1AZ	ACTIB
TESTOSTERONE	3XMK78S47O	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
cd010bde-5b72-f1ae-e053-2a95a90a9b21			5df9393e-b51e-1a8e-e053-2a91aa0a0907	2021-09-27		Exact identifier spl set id: 5df9393e-b51e-1a8e-e053-2a91aa0a0907

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.